CPO-100

· Conjupro Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPO-100, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors [Phase 1]